1.Live biotherapeutic products: the forefront of innovative drug development driven by biotechnology.
Danyang ZOU ; Yumeng DONG ; Jingyu CHEN
Chinese Journal of Biotechnology 2023;39(4):1275-1289
		                        		
		                        			
		                        			As human microbiome research advances, a large body of evidence shows that microorganisms are closely related to human health. Probiotics were discovered and used as foods or dietary supplements with health benefits in the last century. Microorganisms have shown broader application prospects in human health since the turn of the century, owing to the rapid development of technologies such as microbiome analysis, DNA synthesis and sequencing, and gene editing. In recent years, the concept of "next-generation probiotics" has been proposed as new drugs, and microorganisms are considered as "live biotherapeutic products (LBP)". In a nutshell, LBP is a living bacterial drug that can be used to prevent or treat certain human diseases and indications. Because of its distinct advantages, LBP has risen to the forefront of drug development research and has very broad development prospects. This review introduces the varieties and research advances on LBP from a biotechnology standpoint, followed by summarizing the challenges and opportunities for LBP clinical implementations, with the aim to facilitate LBP development.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Probiotics
		                        			;
		                        		
		                        			Dietary Supplements
		                        			;
		                        		
		                        			Bacteria
		                        			;
		                        		
		                        			Drug Development
		                        			;
		                        		
		                        			Biotechnology
		                        			
		                        		
		                        	
2.Preface to the special issue: biotechnology of plastic waste degradation and valorization.
Jie ZHOU ; Tianyuan SU ; Min JIANG ; Qingsheng QI
Chinese Journal of Biotechnology 2023;39(5):1861-1866
		                        		
		                        			
		                        			Synthetic plastics have been widely used in various fields of the national economy and are the pillar industry. However, irregular production, plastic product use, and plastic waste piling have caused long-term accumulation in the environment, contributing considerably to the global solid waste stream and environmental plastic pollution, which has become a global problem to be solved. Biodegradation has recently emerged as a viable disposal method for a circular plastic economy and has become a thriving research area. In recent years, important breakthroughs have been made in the screening, isolation, and identification of plastic-degrading microorganisms/enzyme resources and their further engineering, which provide new ideas and solutions for treating microplastics in the environment and the closed-loop bio-recycling of waste plastics. On the other hand, the use of microorganisms (pure cultures or consortia) to further transform different plastic degradants into biodegradable plastics and other compounds with high added value is of great significance, promoting the development of a plastic recycling economy and reducing the carbon emission of plastics in their life cycle. We edited a Special Issue on the topic of "Biotechnology of Plastic Waste Degradation and Valorization", focusing on the researches progress in three aspects: Mining microbial and enzyme resources for plastic biodegradation, Design and engineering of plastic depolymerase, and biological high-value transformation of plastic degradants. In total, 16 papers have been collected in this issue including reviews, comments, and research articles, which provide reference and guidance for further development of plastic waste degradation and valorization biotechnology.
		                        		
		                        		
		                        		
		                        			Biodegradable Plastics
		                        			;
		                        		
		                        			Biodegradation, Environmental
		                        			;
		                        		
		                        			Biotechnology
		                        			
		                        		
		                        	
3.The degradation of plastics and the production of polyhydroxyalkanoates (PHA).
Zonghao ZHANG ; Hongtao HE ; Xu ZHANG ; Shuang ZHENG ; Taoran ZHENG ; Xu LIU ; Guoqiang CHEN
Chinese Journal of Biotechnology 2023;39(5):2053-2069
		                        		
		                        			
		                        			In recent years, the petroleum-based plastic pollution problem has been causing global attention. The idea of "degradation and up-cycling of plastics" was proposed for solving the environmental pollution caused by non-degradable plastics. Following this idea, plastics would be firstly degraded and then reconstructed. Polyhydroxyalkanoates (PHA) can be produced from the degraded plastic monomers as a choice to recycle among various plastics. PHA, a family of biopolyesters synthesized by many microbes, have attracted great interest in industrial, agricultural and medical sectors due to its biodegradability, biocompatibility, thermoplasticity and carbon neutrality. Moreover, the regulations on PHA monomer compositions, processing technology, and modification methods may further improve the material properties, making PHA a promising alternative to traditional plastics. Furthermore, the application of the "next-generation industrial biotechnology (NGIB)" utilizing extremophiles for PHA production is expected to enhance the PHA market competitiveness, promoting this environmentally friendly bio-based material to partially replace petroleum-based products, and achieve sustainable development with carbon-neutrality. This review summarizes the basic material properties, plastic upcycling via PHA biosynthesis, processing and modification methods of PHA, and biosynthesis of novel PHA.
		                        		
		                        		
		                        		
		                        			Polyhydroxyalkanoates
		                        			;
		                        		
		                        			Plastics
		                        			;
		                        		
		                        			Biotechnology
		                        			;
		                        		
		                        			Petroleum
		                        			;
		                        		
		                        			Carbon
		                        			
		                        		
		                        	
4.Advances on the microbial synthesis of plant-derived diterpenoids.
Yatian CHENG ; Hao TANG ; Lili SUN ; Yating HU ; Ying MA ; Juan GUO ; Luqi HUANG
Chinese Journal of Biotechnology 2023;39(6):2265-2283
		                        		
		                        			
		                        			Natural plant-derived diterpenoids are a class of compounds with diverse structures and functions. These compounds are widely used in pharmaceuticals, cosmetics and food additives industries because of their pharmacological properties such as anticancer, anti-inflammatory and antibacterial activities. In recent years, with the gradual discovery of functional genes in the biosynthetic pathway of plant-derived diterpenoids and the development of synthetic biotechnology, great efforts have been made to construct a variety of diterpenoid microbial cell factories through metabolic engineering and synthetic biology, resulting in gram-level production of many compounds. This article summarizes the construction of plant-derived diterpenoid microbial cell factories through synthetic biotechnology, followed by introducing the metabolic engineering strategies applied to improve plant-derived diterpenoids production, with the aim to provide a reference for the construction of high-yield plant-derived diterpenoid microbial cell factories and the industrial production of diterpenoids.
		                        		
		                        		
		                        		
		                        			Diterpenes/metabolism*
		                        			;
		                        		
		                        			Biotechnology
		                        			;
		                        		
		                        			Metabolic Engineering
		                        			;
		                        		
		                        			Biosynthetic Pathways/genetics*
		                        			;
		                        		
		                        			Plants/genetics*
		                        			;
		                        		
		                        			Synthetic Biology
		                        			
		                        		
		                        	
5.DUS testing guidelines for new varieties of Chinese medicinal plants.
Cheng-Cai ZHANG ; Chao FANG ; Ming QIN ; Hong-Yang WANG ; Xiu-Zhi GUO ; Yue-Feng WANG ; Bin-Bin YAN ; Zi-Hua ZHANG ; Sheng WANG ; Lan-Ping GUO
China Journal of Chinese Materia Medica 2023;48(11):2896-2903
		                        		
		                        			
		                        			A rich diversity of wild medicinal plant resources is distributed in China, but the breeding of new plant varieties of Chinese medicinal plants started late and the breeding level is relatively weak. Chinese medicinal plant resources are the foundation for new varieties breeding, and the plant variety rights(PVP) are of great significance for the protection and development of germplasm resources. However, most Chinese medicinal plants do not have a distinctness, uniformity, and stability(DUS) testing guideline. The Ministry of Agriculture and Rural Affairs has put 191 plant species(genera) on protection lists, of which only 30 are medicinal species(genera). At the same time, only 29 of 293 species(genera) plants in the Protection List of New Plant Varieties of the People's Republic of China(Forest and Grass) belong to Chinese medicinal plants. The number of PVP applications and authorization of Chinese medicinal plants is rare, and the composition of variety is unreasonable. Up to now, 29 species(genera) of DUS test guidelines for Chinese medicinal plants have been developed. Some basic problems in the breeding of new varieties of Chinese medicinal plants have appeared, such as the small number of new varieties and insufficient utilization of Chinese medicinal plant resources. This paper reviewed the current situation of breeding of new varieties of Chinese medicinal plants and the research progress of DUS test guidelines in China and discussed the application of biotechnology in the field of Chinese medicinal plant breeding and the existing problems in DUS testing. This paper guides the further application of DUS to protect and utilize the germplasm resources of Chinese medicinal plants.
		                        		
		                        		
		                        		
		                        			Agriculture
		                        			;
		                        		
		                        			Biotechnology
		                        			;
		                        		
		                        			Plant Breeding
		                        			;
		                        		
		                        			Plants, Medicinal/genetics*
		                        			
		                        		
		                        	
6.Teaching reform and practice of 'Production Internship' course for biotechnology specialty from the perspective of training application-oriented talents.
Bin DONG ; Jun WANG ; Tao WU ; Bin LIU ; Zhiwei SU ; Liping ZHAO ; Hanjie ZHANG ; Xinming WU ; Shijun FU ; Nannan LIU ; Chunlong SUN ; Zhigang YAO
Chinese Journal of Biotechnology 2023;39(2):755-768
		                        		
		                        			
		                        			Production internship is an important teaching tache for undergraduate students to carry out engineering training by using professional skills, and it is a key starting point for fostering application-oriented talents in biotechnology. The Course Group of 'production internship of biotechnology majors' of Binzhou University is investigating application-oriented transformation for local regular colleges and universities, as well as fostering high-level application-oriented talents. By taking green fluorescent protein (GFP) polyclonal antibody as an example, the reform and practice on teaching content, teaching mode, assessment method, continuous improvement of curriculum were carried out. Moreover, the characteristics of the Yellow River Delta-Binzhou Biotechnology & Pharmaceutical Industrial Cluster were taken into account to intensify academic-enterprise cooperation. On one hand, this Course Group designed and rearranged the course contents, carried out essential training through online resources and platforms such as virtual simulation, and recorded, tracked and monitored the progress of production internship through practical testing and software platforms like 'Alumni State'. On the other hand, this Course Group established a practice-and application-oriented assessment method in the process of production internship and a dual evaluation model for continuous improvement. These reform and practices have promoted the training of application-oriented talents in biotechnology, and may serve as a reference for similar courses.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Internship and Residency
		                        			;
		                        		
		                        			Curriculum
		                        			;
		                        		
		                        			Students
		                        			;
		                        		
		                        			Biotechnology
		                        			
		                        		
		                        	
7.Engineering and process management-based design of Comprehensive Biotechnology Experiment course.
Changbin GONG ; Fei CAO ; Honghua JIA ; Kequan CHEN ; Ganlu LI ; Bingfang HE
Chinese Journal of Biotechnology 2023;39(2):769-779
		                        		
		                        			
		                        			Based on the demand of enterprise talents and the characteristics of manufacturing process management in biotechnology, in order to make the students acquire the ability to solve complex engineering problems in the production process, we developed a "Comprehensive Biotechnology Experiment" course, where two-step enzymatic production of l-aspartate and l-alanine were the key processes. In this course, we drew lessons from the site management of the production enterprise, performed the experimental operation mode of four shifts and three operations. The content of this course includes principles, methods and experimental techniques of several core curricula and the site management mode of enterprises. As to the evaluation, the summary of the experimental staff's handover records and the content of teamwork were examined and scored. Through teaching practice and continuous improvement, we developed a complete experimental teaching process and assessment mechanism. Overall, the Comprehensive Biotechnology Experiment course achieved good teaching effect, which may serve as a reference to promote the development of experimental teaching of biotechnology.
		                        		
		                        		
		                        		
		                        			Humans
		                        			;
		                        		
		                        			Biotechnology
		                        			;
		                        		
		                        			Curriculum
		                        			;
		                        		
		                        			Students
		                        			
		                        		
		                        	
8.Biomanufacturing driven by engineered organisms (2022).
Chinese Journal of Biotechnology 2023;39(3):807-841
		                        		
		                        			
		                        			This article summarizes the reviews and original research papers published in Chinese Journaol of Biotechnology in the area of biomanufacturing driven by engineered organisms in the year of 2022. The enabling technologies including DNA sequencing, DNA synthesis, and DNA editing as well as regulation of gene expression and in silico cell modeling were highlighted. This was followed by discussing the biomanufacturing of biocatalytics products, amino acids and its derivatives, organic acids, natural products, antibiotics and active peptides, functional polysaccharides, and functional proteins. Lastly, the technologies for utilizing C1 compounds and biomass as well as synthetic microbial consortia were discussed. The aim of this article was to help the readers to gain insights into this rapidly developing field from the journal point of view.
		                        		
		                        		
		                        		
		                        			Biotechnology
		                        			;
		                        		
		                        			Microbial Consortia
		                        			;
		                        		
		                        			DNA
		                        			;
		                        		
		                        			Biological Products
		                        			;
		                        		
		                        			Publications
		                        			;
		                        		
		                        			Synthetic Biology
		                        			
		                        		
		                        	
9.Biomanufacturing of bioactive compounds: current situation, challenges, and future perspectives.
Tingting YANG ; Congcong CAO ; Yi LIU ; Zhen LU ; Ruiyan WANG
Chinese Journal of Biotechnology 2023;39(11):4335-4357
		                        		
		                        			
		                        			Biomanufacturing uses biological systems, including cells, microorganisms, and enzymes, to produce natural or synthetic molecules with biological activities for use in various industries, such as pharmaceuticals, cosmetics, and agriculture. These bioactive compounds are expected to play important roles in improving the quality of life and prolonging its length. Fortunately, recent advances in synthetic biology and automation technologies have accelerated the development of biomanufacturing, enabling us to create new products and replace conventional methods in a more sustainable manner. As of now, the role of biomanufacturing in the growth and innovation of bioeconomy is steadily increasing, and this techbology becomes a prevalent technology in global markets. To gain a comprehensive understanding of this field, this article presents a retrospective review of Bloomage Biotechnology's Research and Development and briefly reviews the developments of biomanufacturing and offers insights into the futre prospects. In conclusion, biomanufacturing will continue to be an important, environmentally friendly, and sustainable production mode in the ongoing development of bioeconomy.
		                        		
		                        		
		                        		
		                        			Quality of Life
		                        			;
		                        		
		                        			Biotechnology
		                        			;
		                        		
		                        			Agriculture
		                        			;
		                        		
		                        			Synthetic Biology
		                        			;
		                        		
		                        			Industry
		                        			
		                        		
		                        	
10.Advances in the application of yeast surface display technology.
Lili ZHAO ; Bingkai SU ; Shushu DU ; Wenting DING ; Rongzeng LIU
Chinese Journal of Biotechnology 2023;39(11):4358-4375
		                        		
		                        			
		                        			Yeast surface display (YSD) is a technology that fuses the exogenous target protein gene sequence with a specific vector gene sequence, followed by introduction into yeast cells. Subsequently, the target protein is expressed and localized on the yeast cell surface by using the intracellular protein transport mechanism of yeast cells, whereas the most widely used YSD system is the α-agglutinin expression system. Yeast cells possess the eukaryotic post-translational modification mechanism, which helps the target protein fold correctly. This mechanism could be used to display various eukaryotic proteins, including antibodies, receptors, enzymes, and antigenic peptides. YSD has become a powerful protein engineering tool in biotechnology and biomedicine, and has been used to improve a broad range of protein properties including affinity, specificity, enzymatic function, and stability. This review summarized recent advances in the application of YSD technology from the aspects of library construction and screening, antibody engineering, protein engineering, enzyme engineering and vaccine development.
		                        		
		                        		
		                        		
		                        			Saccharomyces cerevisiae/metabolism*
		                        			;
		                        		
		                        			Protein Engineering
		                        			;
		                        		
		                        			Biotechnology
		                        			;
		                        		
		                        			Antibodies/metabolism*
		                        			;
		                        		
		                        			Amino Acid Sequence
		                        			
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail